4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001193125-25-291734
Director sold 1,300,000 shares at an average $20.23 ($26,304,500)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MANCHESTER KEITH S Director | 2025-11-19 | Sale | −850,000 | $20.25 | $17,212,500 | 18,497,727 | I: show line 1 in the form |
| MANCHESTER KEITH S Director | 2025-11-19 | Sale | −150,000 | $20.20 | $3,030,000 | 18,347,727 | I: show line 2 in the form |
| MANCHESTER KEITH S Director | 2025-11-19 | Sale | −125,000 | $20.16 | $2,520,000 | 18,222,727 | I: show line 3 in the form |
| MANCHESTER KEITH S Director | 2025-11-19 | Sale | −175,000 | $20.24 | $3,542,000 | 18,047,727 | I: show line 4 in the form |
| Open-market sales · 1,300,000 sh · avg $20.23 · $26,304,500 | |||||||
Loading xslF345X05/ownership.xml…